Ionic silver and Deformity - a phase IV clinical study of FDA data
Summary:
We study 13,761 people who take Ionic silver (colloidal silver) or have Deformity. No report of Deformity is found in people who take Ionic silver.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Ionic Silver?
Ionic silver has active ingredients of colloidal silver. eHealthMe is studying from 3 Ionic silver users. Check the latest studies of Ionic silver.
What is Deformity?
Deformity (disfigurement) is found to be associated with 930 drugs and 696 conditions by eHealthMe. Check the latest studies of Deformity.
No report is found.
Do you take Ionic silver and have Deformity?
- Check whether Deformity is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Ionic silver:
- Ionic silver (3 reports)
Deformity treatments and more:
- Deformity (13,758 reports)
How severe was Deformity and when was it recovered:
Expand to all the drugs that have ingredients of colloidal silver:
Browse all side effects of Ionic silver:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Deformity:
Browse all the conditions that are associated with Deformity:
How the study uses the data?
The study uses data from the FDA. It is based on colloidal silver (the active ingredients of Ionic silver) and Ionic silver (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Vicodin and Catapres-Tts-1 - a second ago
- Could Neosporin cause General Physical Health Deterioration? - 14 seconds ago
- Drug interactions of Decitabine and Ramipril - 14 seconds ago
- Drug interactions of Fentanyl and Mycelex - 20 seconds ago
- Could Allegra-D 12 Hour cause Dizziness? - 22 seconds ago
- Tykerb and Capecitabine drug interactions for men aged 60+ - 31 seconds ago
- Methamphetamine Hydrochloride vs. Adderall 10, side effect and effectiveness comparison - 35 seconds ago
- Autoimmune Hepatitis and C-Reactive Protein Increased - 40 seconds ago
- Drug interactions of Lopurin and Raltegravir - 42 seconds ago
- Aspirin and Magnesium drug interactions for women aged 20-29 - 45 seconds ago